Filing Details
- Accession Number:
- 0000899243-21-028760
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-16 21:30:18
- Reporting Period:
- 2021-07-15
- Accepted Time:
- 2021-07-16 21:30:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1403752 | Zymeworks Inc. | ZYME | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1761853 | Ali Tehrani | C/O Zymeworks Inc. 1385 West 8Th Avenue, Suite 540 Vancouver A1 V6H 3V9 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2021-07-15 | 3,800 | $4.27 | 264,125 | No | 4 | M | Direct | |
Common Shares | Disposition | 2021-07-15 | 3,800 | $36.00 | 260,325 | No | 4 | S | Direct | |
Common Shares | Acquisiton | 2021-07-16 | 41,191 | $4.26 | 301,516 | No | 4 | M | Direct | |
Common Shares | Disposition | 2021-07-16 | 41,191 | $36.00 | 260,325 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Stock Option (Right to Buy) | Disposition | 2021-07-15 | 3,800 | $0.00 | 3,800 | $4.27 |
Common Shares | Stock Option (Right to Buy) | Disposition | 2021-07-16 | 41,191 | $0.00 | 41,191 | $4.26 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
41,191 | 2013-01-01 | 2022-01-01 | No | 4 | M | Direct |
0 | 2013-01-01 | 2022-01-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares | 55,511 | Indirect | Held by spouse |
Footnotes
- Pursuant to a 10b5-1 plan entered into May 13, 2021.
- The exercise price of the stock option is CAD5.37. The U.S. dollar equivalent of the exercise price is $4.2713 using the Bank of Canada exchange rate for July 15, 2021 (CAD1.00 = $0.7954).
- All shares were sold at $36.00 per share.
- The exercise price of the stock option is CAD5.37. The U.S. dollar equivalent of the exercise price is $4.2643 using the Bank of Canada exchange rate for July 16, 2021 (CAD1.00 = $0.7941).
- Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of January 1, 2012 and (ii) remainder of underlying shares in 36 equal monthly installments on the last day of month following first anniversary of grant date.